HRP20050040A2 - Stabilization of the profile of release of active supstances from a formulation - Google Patents

Stabilization of the profile of release of active supstances from a formulation

Info

Publication number
HRP20050040A2
HRP20050040A2 HR20050040A HRP20050040A HRP20050040A2 HR P20050040 A2 HRP20050040 A2 HR P20050040A2 HR 20050040 A HR20050040 A HR 20050040A HR P20050040 A HRP20050040 A HR P20050040A HR P20050040 A2 HRP20050040 A2 HR P20050040A2
Authority
HR
Croatia
Prior art keywords
formulation
profile
active
supstances
stabilization
Prior art date
Application number
HR20050040A
Other languages
English (en)
Croatian (hr)
Inventor
Resman Aleksander
Fercej Temeljotov Darja
Humar Vlasta
Opresnik Marko
Original Assignee
LEK farmacevtska družba d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK farmacevtska družba d.d. filed Critical LEK farmacevtska družba d.d.
Publication of HRP20050040A2 publication Critical patent/HRP20050040A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HR20050040A 2002-07-17 2005-01-14 Stabilization of the profile of release of active supstances from a formulation HRP20050040A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200179A SI21256A (sl) 2002-07-17 2002-07-17 Stabilizacija profila sproščanja učinkovin iz formulacije
PCT/SI2003/000025 WO2004006888A2 (en) 2002-07-17 2003-07-15 Stabilization of the profile of release of active substances from a formulation

Publications (1)

Publication Number Publication Date
HRP20050040A2 true HRP20050040A2 (en) 2006-11-30

Family

ID=30113493

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050040A HRP20050040A2 (en) 2002-07-17 2005-01-14 Stabilization of the profile of release of active supstances from a formulation

Country Status (10)

Country Link
US (1) US20060083759A1 (xx)
EP (1) EP1524965A2 (xx)
AU (1) AU2003248615B2 (xx)
HR (1) HRP20050040A2 (xx)
PL (1) PL372771A1 (xx)
RS (1) RS20050038A (xx)
RU (1) RU2354387C2 (xx)
SI (1) SI21256A (xx)
UA (1) UA89020C2 (xx)
WO (1) WO2004006888A2 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283824B1 (en) * 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5919489A (en) * 1995-11-01 1999-07-06 Abbott Laboratories Process for aqueous granulation of clarithromycin
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
WO2001068662A1 (en) * 2000-03-15 2001-09-20 Hanmi Pharm. Co., Ltd. Method of preparing clarithromycin of form ii crystals
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system

Also Published As

Publication number Publication date
SI21256A (sl) 2004-02-29
RU2005104423A (ru) 2006-01-27
PL372771A1 (en) 2005-08-08
RS20050038A (xx) 2007-06-04
UA89020C2 (ru) 2009-12-25
RU2354387C2 (ru) 2009-05-10
AU2003248615B2 (en) 2006-11-16
AU2003248615A1 (en) 2004-02-02
WO2004006888A3 (en) 2004-04-29
EP1524965A2 (en) 2005-04-27
WO2004006888A2 (en) 2004-01-22
US20060083759A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
CY1120994T1 (el) Καινοτομες συνθεσεις διαλυματος που περιεχουν κυτταρικο παραγοντα και χρηση αυτων για τη θεραπεια τραυματων
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
WO2020083971A3 (en) New anthelmintic compounds
CL2008003486A1 (es) 6-oxo-1,6-dihidropiridazinas; sus usos para tratar un trastorno hiperproliferativo; la composición farmacéutica que las contiene; y sus procesos de preparación (div. sol. 1168-06).
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
MY154869A (en) Composition for treating metabolic syndrome
CR8402A (es) Indazol-o-glucosidos sustitutos
EA200401494A1 (ru) Бактерицидные пиримидины или триазины для профилактики передачи вич половым путём
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
BRPI0911035B8 (pt) ativadores de pirrolidinona glicoquinase
ATE430743T1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
BRPI0813450B8 (pt) composto, formulação farmacêutica, e, usos do composto
CL2009000906A1 (es) Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
RS53236B (en) BETA-AMYLOIDOSIS PEPTIDES
UA86599C2 (xx) Заміщені бензимідазол-, бензтриазол- та бензимідазолон-о-глюкозиди$замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
WO2010059719A3 (en) Dimeric 1-arylpyrazole derivatives
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
CL2008003472A1 (es) Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias.
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
PH12020551076A1 (en) Methods for treating diabetes, hepatitis, and/or inflammatory liver disease
PL376176A1 (en) Solid preparation
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
HRP20050040A2 (en) Stabilization of the profile of release of active supstances from a formulation
AR072426A1 (es) Uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonadida

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090713

Year of fee payment: 7

OBST Application withdrawn